Role of the Intestinal Microbiota in the Molecular Pathogenesis of Atypical Parkinsonian Syndromes DOI Open Access
Dominika Przewodowska, Piotr Alster, Natalia Madetko‐Alster

и другие.

International Journal of Molecular Sciences, Год журнала: 2025, Номер 26(9), С. 3928 - 3928

Опубликована: Апрель 22, 2025

The role of the intestinal microbiota and its influence on neurodegenerative disorders has recently been extensively explored, especially in context Parkinson’s disease (PD). In particular, immunomodulation, impact inflammation, participation gut–brain axis are under ongoing investigations. Recent studies have revealed new data that could be important for exploring neurodegeneration mechanisms connected with gut microbiota, potentially leading to development methods treatment. this review, potential roles future disease-modifying therapies were discussed properties microbiota—including impacts metabolism short-chain fatty acids vitamins—were summarized, a particular focus atypical Parkinsonian syndromes. This review focused detailed description numerous through which influences processes. explored connections between evolution progression Finally, derived results regarding alterations syndromes comparison previously described PD was also included.

Язык: Английский

Role of the Intestinal Microbiota in the Molecular Pathogenesis of Atypical Parkinsonian Syndromes DOI Open Access
Dominika Przewodowska, Piotr Alster, Natalia Madetko‐Alster

и другие.

International Journal of Molecular Sciences, Год журнала: 2025, Номер 26(9), С. 3928 - 3928

Опубликована: Апрель 22, 2025

The role of the intestinal microbiota and its influence on neurodegenerative disorders has recently been extensively explored, especially in context Parkinson’s disease (PD). In particular, immunomodulation, impact inflammation, participation gut–brain axis are under ongoing investigations. Recent studies have revealed new data that could be important for exploring neurodegeneration mechanisms connected with gut microbiota, potentially leading to development methods treatment. this review, potential roles future disease-modifying therapies were discussed properties microbiota—including impacts metabolism short-chain fatty acids vitamins—were summarized, a particular focus atypical Parkinsonian syndromes. This review focused detailed description numerous through which influences processes. explored connections between evolution progression Finally, derived results regarding alterations syndromes comparison previously described PD was also included.

Язык: Английский

Процитировано

0